These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30971640)

  • 1. Metformin Attenuates Early-Stage Atherosclerosis in Mildly Hyperglycemic Oikawa-Nagao Mice.
    Asai A; Shuto Y; Nagao M; Kawahara M; Miyazawa T; Sugihara H; Oikawa S
    J Atheroscler Thromb; 2019 Dec; 26(12):1075-1083. PubMed ID: 30971640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of impaired glucose tolerance on atherosclerotic lesion formation: an evaluation in selectively bred mice with different susceptibilities to glucose intolerance.
    Asai A; Nagao M; Kawahara M; Shuto Y; Sugihara H; Oikawa S
    Atherosclerosis; 2013 Dec; 231(2):421-6. PubMed ID: 24267261
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leptin production capacity determines food intake and susceptibility to obesity-induced diabetes in Oikawa-Nagao Diabetes-Prone and Diabetes-Resistant mice.
    Asai A; Nagao M; Hayakawa K; Miyazawa T; Sugihara H; Oikawa S
    Diabetologia; 2020 Sep; 63(9):1836-1846. PubMed ID: 32561946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Repetitive Glucose Spikes Accelerate Atherosclerotic Lesion Formation in C57BL/6 Mice.
    Shuto Y; Asai A; Nagao M; Sugihara H; Oikawa S
    PLoS One; 2015; 10(8):e0136840. PubMed ID: 26313920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin beyond diabetes: pleiotropic benefits of metformin in attenuation of atherosclerosis.
    Forouzandeh F; Salazar G; Patrushev N; Xiong S; Hilenski L; Fei B; Alexander RW
    J Am Heart Assoc; 2014 Dec; 3(6):e001202. PubMed ID: 25527624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metformin inhibited Nod-like receptor protein 3 inflammasomes activation and suppressed diabetes-accelerated atherosclerosis in apoE
    Tang G; Duan F; Li W; Wang Y; Zeng C; Hu J; Li H; Zhang X; Chen Y; Tan H
    Biomed Pharmacother; 2019 Nov; 119():109410. PubMed ID: 31518877
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.
    Matsui Y; Hirasawa Y; Sugiura T; Toyoshi T; Kyuki K; Ito M
    Biol Pharm Bull; 2010; 33(6):963-70. PubMed ID: 20522960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selectively bred rodent models for studying the etiology of type 2 diabetes: Goto-Kakizaki rats and Oikawa-Nagao mice.
    Nagao M; Asai A; Eliasson L; Oikawa S
    Endocr J; 2023 Jan; 70(1):19-30. PubMed ID: 36477370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C57BL/6 mice fed high fat diets as models for diabetes-accelerated atherosclerosis.
    Schreyer SA; Wilson DL; LeBoeuf RC
    Atherosclerosis; 1998 Jan; 136(1):17-24. PubMed ID: 9544727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [D-LEU-4]-OB3, a synthetic leptin agonist, improves hyperglycemic control in C57BL/6J ob/ob mice.
    Grasso P; Rozhavskaya-Arena M; Leinung MC; Lee DW
    Regul Pept; 2001 Sep; 101(1-3):123-9. PubMed ID: 11495687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
    Freemark M; Bursey D
    Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two weeks of metformin treatment on whole-body glycocalyx barrier properties in db/db mice.
    Eskens BJ; Zuurbier CJ; van Haare J; Vink H; van Teeffelen JW
    Cardiovasc Diabetol; 2013 Dec; 12():175. PubMed ID: 24308370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased atherosclerosis in streptozotocin-induced diabetic mice.
    Kunjathoor VV; Wilson DL; LeBoeuf RC
    J Clin Invest; 1996 Apr; 97(7):1767-73. PubMed ID: 8601643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoglycemic and hypolipidemic effects of Coriandrum sativum L. in Meriones shawi rats.
    Aissaoui A; Zizi S; Israili ZH; Lyoussi B
    J Ethnopharmacol; 2011 Sep; 137(1):652-61. PubMed ID: 21718774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antidiabetic effects of the Cimicifuga racemosa extract Ze 450 in vitro and in vivo in ob/ob mice.
    Moser C; Vickers SP; Brammer R; Cheetham SC; Drewe J
    Phytomedicine; 2014 Sep; 21(11):1382-9. PubMed ID: 25022210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin: effects on micro and macrovascular complications in type 2 diabetes.
    Bailey CJ
    Cardiovasc Drugs Ther; 2008 Jun; 22(3):215-24. PubMed ID: 18288595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiatherogenic effects of liraglutide in hyperglycemic apolipoprotein E-null mice via AMP-activated protein kinase-independent mechanisms.
    Koshibu M; Mori Y; Saito T; Kushima H; Hiromura M; Terasaki M; Takada M; Fukui T; Hirano T
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E895-E907. PubMed ID: 30860874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of extensive atherosclerosis, coronary artery disease and myocardial infarction in the ApoE
    Venegas-Pino DE; Lagrotteria A; Wang PW; Morphet J; Clapdorp C; Shi Y; Werstuck GH
    Atherosclerosis; 2018 Aug; 275():88-96. PubMed ID: 29879686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Effects of Metformin on Obesity-Induced Dysfunctional Retinas.
    Kim AJ; Chang JY; Shi L; Chang RC; Ko ML; Ko GY
    Invest Ophthalmol Vis Sci; 2017 Jan; 58(1):106-118. PubMed ID: 28114566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-diabetic atherosclerosis effect of Prunella vulgaris in db/db mice with type 2 diabetes.
    Hwang SM; Kim JS; Lee YJ; Yoon JJ; Lee SM; Kang DG; Lee HS
    Am J Chin Med; 2012; 40(5):937-51. PubMed ID: 22928826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.